rhmpv-pa vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2011 (NCT01255410)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human metapneumovirusImmunity, active
Human metapneumovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhmpv-pa vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07295028 | Phase 1 | Nov 17, 2025 | Emeritus Research, Veritas Research., Corp., Vicebio |
| NCT01255410 | Phase 1 | Jan 1, 2011 | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Emeritus Research | For profit | 1 | 0 | 1 | 2025 |
| Johns Hopkins University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2011 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 2011 |
| Veritas Research., Corp. | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Vicebio | For profit | 1 | 1 | 1 | 2025 |
6 organizations
Page 1 / 1